AIRS

Airsculpt Technologies Inc
NASDAQHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$297.70M
P/E Ratio
EPS
$-0.17
Beta
2.37
52W High
$12.00
52W Low
$1.51
50-Day MA
$4.51
200-Day MA
$4.32
Dividend Yield
Profit Margin
-7.39%
Forward P/E
PEG Ratio

About Airsculpt Technologies Inc

Airsculpt Technologies Inc (AIRS) is a leader in the aesthetic medical technology industry, recognized for its proprietary AirSculpt® procedure that offers a minimally invasive approach to body contouring while prioritizing patient safety and comfort. The company is actively expanding its network of licensed practitioners, leveraging technological innovations to strengthen its competitive edge in the burgeoning non-invasive cosmetic treatment market. With increasing global consumer interest in aesthetic solutions, Airsculpt is strategically positioned to enhance market share and diversify its service portfolio, thereby driving significant growth and sustainable value for its investors.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$151.84M
Gross Profit (TTM)$100.31M
EBITDA$7.51M
Operating Margin-4.58%
Return on Equity-12.60%
Return on Assets-1.60%
Revenue/Share (TTM)$2.40
Book Value$1.42
Price-to-Book3.18
Price-to-Sales (TTM)1.96
EV/Revenue2.458
EV/EBITDA403.45
Quarterly Earnings Growth (YoY)200.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$70.55M
Float$14.96M
% Insiders43.06%
% Institutions66.03%

Historical Volatility

HV 10-Day
41.05%
HV 20-Day
57.31%
HV 30-Day
66.02%
HV 60-Day
87.01%
HV Rank

Volatility is currently contracting

Analyst Ratings

Consensus ($4.50 target)
2
Hold

Latest News

AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions

HONG KONG & SEOUL, South Korea--(BUSINESS WIRE)--AIRS Medical (“the Company”), a global leader in AI solutions for medical imaging, today announced a strategic growth investment from TA Associates (“TA”), a leading global private equity firm. The investment will help fuel AIRS Medical's next phase of global expansion, advancement of its AI-powered radiology technology solutions and ongoing product innovation. Founded in 2018, AIRS Medical develops AI-native magnetic resonance imaging (“MRI”) ac.

Business Wire6/16/2026Neutral
AirSculpt Technologies Announces Participation in Upcoming Investor Conferences

MIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences.

GlobeNewsWire5/27/2026Neutral
AirSculpt Technologies Q1 Earnings Call Highlights

AirSculpt Technologies NASDAQ: AIRS reported first-quarter fiscal 2026 results that management characterized as a “key turning point,” citing stabilized revenue, the first positive same-center sales result in more than two years, and continued debt reduction. Get AirSculpt Technologies alerts:Sign UpQ1 results: flat revenue, positive same-center sales, and margin expansion Chief Executive Officer Yogi Jashnani said the company “stabilized revenue year-over-year and delivered positive same-center sales for the first time in over two years,” while also expanding gross margin.

MarketBeat5/8/2026Positive
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results

MIAMI BEACH, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2026.

GlobeNewsWire5/8/2026Neutral
AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results

MIAMI BEACH, Fla., May 01, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2026 financial results before market open on Friday, May 8, 2026, to be followed by a conference call on the same day at 8:30 a.m.

GlobeNewsWire5/1/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026